New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics

New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganis...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (232 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04166nam-a2201153z--4500
001 993553550104498
005 20231214133635.0
006 m o d
007 cr|mn|---annan
008 202208s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5600000000483079 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/91188 
035 |a (EXLCZ)995600000000483079 
041 0 |a eng 
100 1 |a Felgueiras, Helena  |4 edt 
245 1 0 |a New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (232 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a New approaches to deal with the growing concern associated with antibiotic-resistant bacteria are in great demand. For many years, antibiotics have widely been employed to treat infections. However, their excessive consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which constitute a major challenge to global health. The antibiotic crisis is now a general concern; therefore, alternative biomolecules or drug delivery systems to treat infections are urgently needed. From natural extracts to traditional medicine remedies, to newly engineered nanocapsules and nanoparticles, to bio-based, biodegradable delivery platforms, many systems to fight infections are explored in this book. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Chemistry  |2 bicssc 
653 |a nanoparticles 
653 |a 4-Nerolidylcatechol 
653 |a antifungals 
653 |a Microsporum canis 
653 |a polycaprolactone 
653 |a nanoprecipitation 
653 |a silver nanoparticles 
653 |a green synthesis method 
653 |a Catharanthus roseus 
653 |a Azadirachta indica 
653 |a multidrug-resistant bacteria 
653 |a wound healing 
653 |a nosocomial infection 
653 |a plant extract 
653 |a grapefruit seed extract 
653 |a antibacterial activity 
653 |a fiber-hydrogel composite 
653 |a biodegradable polymers 
653 |a skin regeneration 
653 |a drug delivery platforms 
653 |a controlled release 
653 |a tetramycin 
653 |a antimicrobial activity 
653 |a kiwifruit disease 
653 |a conventional antibiotics 
653 |a storage quality 
653 |a gold nanoparticles 
653 |a flavonoids 
653 |a Gram-negative bacteria 
653 |a DNA gyrase 
653 |a in silico 
653 |a multidrug-resistant Acinetobacter baumannii (MDR-AB) 
653 |a hypertonic saline 
653 |a antibiotics 
653 |a biofilm 
653 |a aerosol delivery 
653 |a ultrahigh-throughput screening 
653 |a live biosensors 
653 |a antibiotic discovery 
653 |a gram-negative pathogens 
653 |a microfluidic droplet cocultivation 
653 |a efficient promoters 
653 |a polymyxins 
653 |a colistin biosynthetic gene cluster 
653 |a single cell 
653 |a multi-omics 
653 |a quercetin 
653 |a magnesium-doped calcium silicate 
653 |a osteogenic activity 
653 |a bone regeneration and nanofiber scaffold 
653 |a bulk-tank milk 
653 |a mastitis 
653 |a methicillin 
653 |a milk 
653 |a goat 
653 |a somatic cell counts 
653 |a staphylococcus 
653 |a tetracycline 
653 |a total bacterial counts 
653 |a prosthetic joint infection 
653 |a local prevention 
653 |a allicin 
653 |a chitosan 
653 |a Sphaerotheca sp. 
653 |a antibiotic 
653 |a Rosa roxburghii 
653 |a cyclic diphenylphosphonate 
653 |a quinoline 
653 |a DNA gyrase inhibitor 
653 |a molecular docking 
653 |a magnesium ion 
776 |z 3-0365-4736-3 
776 |z 3-0365-4735-5 
700 1 |a Felgueiras, Helena  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 06:00:54 Europe/Vienna  |f system  |c marc21  |a 2022-08-13 21:17:26 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339474840004498&Force_direct=true  |Z 5339474840004498  |b Available  |8 5339474840004498